Geriatrics Update 2004 - PowerPoint PPT Presentation


PPT – Geriatrics Update 2004 PowerPoint presentation | free to view - id: 7e690-ZjhmY


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation

Geriatrics Update 2004


Geriatrics Update 2004. Steven Zweig, MD. Family and Community Medicine. MU School of Medicine ... Sample had to be primarily older patients ... – PowerPoint PPT presentation

Number of Views:53
Avg rating:3.0/5.0
Slides: 49
Provided by: fcm3


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Geriatrics Update 2004

Geriatrics Update 2004
  • Steven Zweig, MD
  • Family and Community Medicine
  • MU School of Medicine

  • Sample had to be primarily older patients
  • Either most interesting, most dramatic, or most
    prevalent serves as selection criterion
  • Articles collected over the last year
  • Final selection is thematic and somewhat
  • Common journals searched include JAMA, NEJM,
    JAGS, BMJ, Lancet, JAMDA,reviews from InfoPOEMs,
    abstracts from various sources

Falls and Vitamin D
  • Fall prevention
  • Vitamin D for fall prevention
  • Under use of calcium and vitamin D in nursing

Can we prevent falls in the elderly?
  • Chang JT et al. BMJ 2004328680-687

Background and Design
  • 30 of 65 fall each year, 50 for those over 80
  • 3-10 of falls result in serious injury, leading
    to 40 of nursing home admissions
  • Meta-analysis of all randomized controlled trials
    (RCT) examining impact of fall prevention
    interventions including multifactorial risk
    assessment and management, exercise programs, and

  • 40 trials identified
  • Reduction in risk of falling (risk ratio 0.88,
    95 confidence interval 0.82 to 0.95) and
    reduction in monthly fall rate (rate ratio 0.80,
    0.72 to 0.88)
  • Multifactorial risk assessment and management
    most effective on risk of falling (number needed
    to treat NNT 11) and monthly fall rate (11.8
    fewer falls per 100 persons).
  • Exercise interventions were also effective (NNT

Does Vitamin D reduce the risk of falling?
  • Bischoff-Ferrari HA et al. JAMA

Background and Design
  • Moderate protective effect of vitamin D on
    fracture risk attributed to bone changes
  • Vitamin D may also improve muscle function,
    reduce body sway, and thereby additionally
    reducing fracture risk
  • Meta-analysis to assess effectiveness in
    preventing falls
  • RCTs using vitamin D in elderly including
    community and nursing home subjects

  • Based on 5 RCTs with 1237 participants, vitamin D
    reduced falls (odds ratio OR, 0.78 95 CI,
    0.64-0.92) compared with placebo or calcium. NNT
  • Inclusion of 5 studies for sensitivity analysis
    confirmed benefits of vitamin D
  • Effect size independent of calcium, 800 IU/day
    appears to be required dose

Are we using calcium and vitamin D in nursing
  • Kamel HK. JAMDA 2004598-100.

Background and Design
  • Prevalence of osteoporosis up to 85 in nursing
    homes calcium and vitamin D caused 43 reduction
    in nonvertebral fractures
  • Vitamin D deficient due to age-related decline in
    production, lack of sunlight, and inadequate oral
    intake and absorption
  • This is a cross sectional study of 177 residents
    from one facility in New York

  • Subjects age 65-98 years
  • Calcium and vitamin D prescribed in only 12 and
    9 of subjects more if diagnosis of osteoporosis
    was made, only 25 if history of hip fracture
  • Small study, but points to a simple need for more
    appropriate prescribing of inexpensive and low
    risk drugs

Osteoarthritis of the Knee
  • Osteoarthritis the most common cause of
    disability in the aged
  • Little progress toward cure results in symptom
    oriented therapies recent meta-analysis showed
    limited value of hyaluronate injections
  • Two studies look at steroid injections and knee
    taping as approaches to symptomatic therapy

Do steroid injections work?
  • Arroll B, Goodyear-Smith F. BMJ 2004

Background and Design
  • Most believe intraarticular steroids provide
    short term relief of symptoms
  • Concerns that multiple injections may damage
    articular cartilage
  • This meta-analysis examined RCTs comparing
    steroids to placebo injections
  • 10 trials met inclusion criteria doses ranged
    from 6.25 to 80 mg prednisone equivalents

  • Pooled relative risk for improvement at 16-24
    weeks was 2.09 (95 CI, 1.2 to 3.7), NNT 4.4
  • Higher doses more effective than lower doses,
    especially after 16 or more weeks
  • One study used q 3 month injections for 2 years
    and saw no change in joint space narrowing
    suggesting no negative effects

What is the efficacy of knee taping for DJD?
  • Hinman RS et al. BMJ 2003327-332.

Background and Design
  • Knee taping provides medial glide, medial tilt,
    and AP tilt to the patella to unload
    infrapatellar fat pad or pes anserinus
  • 87 volunteers (mean age 67) randomly allocated
    into therapeutic tape, control tape, and no tape
    groups applied by community physical therapists
    for 3 wks
  • Subjects unaware which was therapeutic, assessors
    of outcomes didnt know subjects group
  • Outcomes included pain, function at 3 weeks and 6

(No Transcript)
Benefits of Knee Taping
  • Therapeutic taping showed benefits in all
    outcomes at 3 and 6 weeks 73 showing
    improvement vs. 49 for control taping and 10
    for no tape group
  • Generally applicable and patients could be taught
    - but not know how pain is relieved or ideal
    duration of taping
  • Simple, inexpensive strategy

Can antidepressants reduce mortality from stroke?
  • Jorge RE et al. Am J Psychiatry 2003

Background and Design
  • Poststroke depression associated with mortality
    for up to 5 years after stroke, diagnosed in 40
    and linked to poorer cognitive and physical
  • 343 patients (mostly from Iowa) evaluated
    poststroke 130 refused, 103 excluded due to
    life-threatening illness or unable
  • 104 (mean age 68) submitted to double-blind
    placebo controlled trial of 12 weeks treatment
    with fluoxetine or nortriptyline vs. placebo and
    mortality determined at 9 years

Survival after Stroke
  • Intention to treat analysis (ITT) showed that 42
    of 71 (59.2) of treated patients were alive at 9
    years vs. 12 of 33(36.4) of placebo patients
    (p.03, log rank test, Kaplan-Meier survival
    analysis), NNT 4
  • Logistic regression controlling for other risk
    factors demonstrated no change in effect
  • No difference between fluoxetine and
    nortriptyline or between depressed vs. not
    depressed at baseline
  • Those treated for longer times did better

What adverse drug reactions (ADRs) are associated
with hospitalization?
  • Pirmhamed M et al. BMJ 2004 32915-19

Background and Design
  • ADRs account for 5 of hospital admissions based
    on studies before 1990
  • Incidence of fatal ADRs may be 0.13
  • More common in elderly patients
  • Prospective study of 18820 patients aged gt16 yrs
    admitted over 6 months to two large British
    hospitals excluded deliberate misuse each case
    reviewed twice and judged as to level of cause
    and avoid ability

  • 1225 (6.5) of admissions caused by ADR
  • Median age 76 years (compared with 66 years for
    those without ADR)
  • In 80 ADR directly responsible for admission
    72 judged to be avoidable
  • Interactions responsible in 15.6 of cases
  • 2 died, suggesting ADRs may be responsible for
    death of 0.15 of those admitted

Causes of ADRs
  • Drugs of cases
  • NSAIDs (c ASA) 29.6
  • Diuretics 27.3
  • Warfarin 10.5
  • ACE inhibitors 7.7
  • Antidepressants 7.1
  • B blockers 6.8
  • Opiates 6.0
  • Digoxin 2.9
  • Prednisone 2.5
  • Clopidogrel 2.4

  • Management of newly detected atrial fibrillation
  • Using BNP to improve outcomes for dyspnea
  • Use of home monitoring to improve blood pressure

What is the appropriate management for new onset
atrial fibrillation?
  • Snow V et al. Ann Intern Med 20031009-1017
  • McNamara RL et al. Ann Intern Med

Background and Design
  • Atrial fibrillation is the most common arrhythmia
    in adults
  • Prevalence increases to 8 in 80 people
  • Palpitations, dizziness, malaise common and risk
    of stroke increased 1 to 7 fold
  • Study group reviewed 500 articles for RCTs
    paired reviewers evaluated efficacy and safety
    excluded postop or postmycardial infarction AF,
    class IV CHF, and valvular heart disease

Results/Recommendations (1)
  • Rate control is recommended strategy for majority
    of patients. Rhythm control not superior to rate
  • Patients should receive warfarin unless low risk
    of stroke or contraindicated (thrombocytopenia,
    recent trauma or surgery, alcoholism)
  • Rate control drugs include atenelol, metoprolol,
    diltiazem, and verapamil. Digoxin effective only
    at rest.

Results/Recommendations (2)
  • For those who elect cardioversion both direct
    current and pharmacological treatments are
    appropriate options
  • Both TE echo with short-term prior
    anticoagulation (in absence of thrombus) and
    delayed cardioversion with anticoagulation are
    appropriate strategies
  • Most patients converted to sinus rhythm should
    not be placed on maintenance therapy.

Does the use of B-type natriuretic peptide (BNP)
improve patient outcomes?
  • Mueller C et al. N Engl J Med 2004350647-654

Background and Design
  • Congestive heart failure (CHF) is the most
    frequent cause of hospitalization in 65
  • BNP higher in CHF than other causes of dyspnea
  • Incorrect treatment strategies costly in and
  • RCT of 452 patients with dyspnea presenting to
    emergency department of University Hospital in
    Basel, Switzerland. One group got BNP, the other
    usual evaluation (patients with trauma, renal
    failure excluded)
  • Outcome assessment blinded to group assignment

  • Clinicians advised that BNP lt 100 made CHF
    unlikely, one of gt500 very likely
  • Mean age 71 years. Admission in BNP group lower
    (75 vs. 85 NNT 10), as was ICU admission (15
    vs. 24 NNT 11)
  • Patients in BNP group treated more quickly (63
    vs. 90 min), spent less time in hospital (8 vs.
    11 days), and cost less (5410 vs. 7264)
  • No difference in in-hospital or 30 day mortality
    or 30 day readmission rates

Does office or home BP predict outcomes?
  • Bobrie G et al. JAMA 2004 2911342-1349

  • For each 10 mmHg systolic or 5 mmHg diastolic
    increase in BP, mortality from stroke up 40 and
    CAD up 30
  • BP control reduces those risks, but measurement
    in office variable

  • To assess the prognostic value of home vs. office
    BP measurements
  • European study included 4939 patients treated for
    hypertension (mean age 70 )
  • Recruited and followed by GPs without specific
    management recommendations
  • Threshold for normal 140/90 in office, 135/85 at
  • Primary outcome cardiovascular mortality, panel
    of 3 blinded to BP measurements

  • Cohort followed an average of 3.2 years Mean of
    6 measurements defined office BP and 27 defined
    home BP
  • At baseline on 13.9 controlled by both home and
    office measures
  • Cardiovascular mortality 5.6/1000 pt-years
  • 9 of patients appeared controlled in the office,
    but were not at home vs. 13 elevated only in
  • After adjustment for age, sex, prior CAD hx,
    smoking home BP linked to prognosis

Can morphine help dyspnea?
  • Abernethy AP et al. BMJ 2003327523-528

  • Breathlessness is a source of distress for 50-70
    of patients requiring palliative care
  • Multifactorial causes include the underlying
    disease, cachexia, and deconditioning
  • While opiates have been used, high quality
    studies have been lacking

  • Randomized double blind eight day crossover study
    of opiate naïve subjects with refractory dyspnea
  • Subjects came from pulmonary, cardiology, and
    palliative care clinics where their physician
    specialists had maximally managed their disease
  • 20 mg of time released morphine taken in the AM
    was the study drug with identical placebo
  • Dyspnea measured on visual analogue scale along
    with exercise tolerance, BP, HR, RR, O2
    saturation, and sleep disturbance

  • Mean age 76, 73 men, most with COPD
  • 38 of 48 subjects completed the study (5 dropped
    out of each of the groups)
  • Subjects receiving morphine reported
    significantly less dyspnea (6.6 mm in AM and 9.5
    mm in PM, plt.01), better sleep (p.o4), and more
    constipation (p.o2)
  • Exertion, respirations, and 02 saturation were
    not affected

Summary Conclusions (1)
  • Falls in the elderly can be reduced with careful
    assessment and exercise programs
  • Vitamin D reduces falls (800 IU/day)
  • Many in nursing homes are receiving inadequate
    calcium and vitamin D
  • Both corticosteroid injections and taping help
    symptoms of osteoarthritis of the knee

Summary Conclusions (2)
  • All patients without a contraindication should
    likely be treated with an antidepressant
    following a stroke
  • ADRs are a common cause of hospitalization of the
    elderly watch ASA, NSAIDs, diuretics, and
  • Focus on rate control and anticoagulation for new
    onset atrial fibrillation

Summary Conclusions (3)
  • BNP improves outcomes in evaluation of dyspnea
  • Home self- blood pressure monitoring better
    predicts outcomes than office readings
  • Sustained release morphine helps refractory
    dyspnea in older persons with minimal side
    effects in most